enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -35.96% | -46.78% | -18.61% | -24.67% | -21.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.37% | -38.00% | -18.01% | -35.09% | -16.14% |
| Operating Income | 12.37% | 38.00% | 18.01% | 35.09% | 16.14% |
| Income Before Tax | 3.79% | 46.22% | 14.52% | 40.02% | 19.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.79% | 46.22% | 14.52% | 40.02% | 19.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.79% | 46.22% | 14.52% | 40.02% | 19.55% |
| EBIT | 12.37% | 38.00% | 18.01% | 35.09% | 16.14% |
| EBITDA | 12.17% | 38.17% | 17.97% | 35.17% | 16.06% |
| EPS Basic | 20.29% | 53.43% | 24.06% | 43.33% | 35.77% |
| Normalized Basic EPS | 25.12% | 44.68% | 24.20% | 38.63% | 34.32% |
| EPS Diluted | 20.29% | 53.43% | 24.06% | 43.33% | 35.77% |
| Normalized Diluted EPS | 25.12% | 44.68% | 24.20% | 38.63% | 34.32% |
| Average Basic Shares Outstanding | 20.70% | 15.49% | 12.56% | 5.83% | 25.25% |
| Average Diluted Shares Outstanding | 20.70% | 15.49% | 12.56% | 5.83% | 25.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |